Goldman Sachs’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,800
Closed -$643K 6489
2025
Q1
$643K Buy
+17,800
New +$548K ﹤0.01% 5028
2020
Q2
Sell
-15,000
Closed -$772K 5522
2020
Q1
$772K Buy
+15,000
New +$782K ﹤0.01% 3930

Other funds holding ZLAB

Goldman Sachs's ZLAB Position: Q1 2026 in Review

Goldman Sachs reduced its Zai Lab (ZLAB) stake by 26% in Q1 2026, selling an estimated $720K and leaving 110,587 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4508.

Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 32 quarters since. The position peaked at $87.8M in Q3 2020. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Goldman Sachs held 110,587 shares of Zai Lab worth $2.08M as of Q1 2026.
  • Goldman Sachs sold 38,847 Zai Lab shares in Q1 2026, an estimated $720K.
  • Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4508 holding.
  • Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 32 quarters since.
  • Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.